Growth Metrics

Integra Lifesciences Holdings (IART) Amortization of Deferred Charges (2016 - 2019)

Integra Lifesciences Holdings (IART) has disclosed Amortization of Deferred Charges for 11 consecutive years, with $1.3 million as the latest value for Q4 2019.

  • Quarterly Amortization of Deferred Charges fell 0.84% to $1.3 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $5.4 million through Dec 2019, down 14.04% year-over-year, with the annual reading at $5.4 million for FY2019, 14.04% down from the prior year.
  • Amortization of Deferred Charges hit $1.3 million in Q4 2019 for Integra Lifesciences Holdings, down from $1.4 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $2.1 million in Q2 2018 to a low of $387000.0 in Q3 2016.
  • Historically, Amortization of Deferred Charges has averaged $958750.0 across 5 years, with a median of $763000.0 in 2016.
  • Biggest five-year swings in Amortization of Deferred Charges: crashed 36.94% in 2017 and later skyrocketed 446.8% in 2018.
  • Year by year, Amortization of Deferred Charges stood at $619000.0 in 2015, then surged by 46.37% to $906000.0 in 2016, then skyrocketed by 70.42% to $1.5 million in 2017, then dropped by 14.7% to $1.3 million in 2018, then dropped by 0.84% to $1.3 million in 2019.
  • Business Quant data shows Amortization of Deferred Charges for IART at $1.3 million in Q4 2019, $1.4 million in Q3 2019, and $1.4 million in Q2 2019.